Brookdale Senior Living (BKD)
(Delayed Data from NYSE)
$6.24 USD
-0.01 (-0.16%)
Updated Nov 4, 2024 04:00 PM ET
After-Market: $6.24 0.00 (0.00%) 4:32 PM ET
3-Hold of 5 3
B Value B Growth F Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$6.24 USD
-0.01 (-0.16%)
Updated Nov 4, 2024 04:00 PM ET
After-Market: $6.24 0.00 (0.00%) 4:32 PM ET
3-Hold of 5 3
B Value B Growth F Momentum B VGM
Zacks News
Down -20.05% in 4 Weeks, Here's Why Brookdale (BKD) Looks Ripe for a Turnaround
by Zacks Equity Research
Brookdale (BKD) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Is Brookdale Senior Living (BKD) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Here is how Brookdale Senior Living (BKD) and BellRing Brands (BRBR) have performed compared to their sector so far this year.
Why Fast-paced Mover Brookdale (BKD) Is a Great Choice for Value Investors
by Zacks Equity Research
Brookdale (BKD) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Ensign Group (ENSG) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Ensign Group (ENSG) delivered earnings and revenue surprises of 2.73% and 4.77%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Fast-paced Momentum Stock Brookdale (BKD) Is Still Trading at a Bargain
by Zacks Equity Research
Brookdale (BKD) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Brookdale (BKD) Q1 Adjusted EBITDA to Beat View, Occupancy Up
by Zacks Equity Research
Brookdale Senior Living (BKD) witnesses 17 straight months of year-over-year increases in weighted average occupancy level.
Brookdale Senior (BKD) February Weighted Average Occupancy Up
by Zacks Equity Research
Brookdale Senior Living (BKD) witnesses 16 straight months of year-over-year increases in weighted average occupancy level.
Brookdale Senior Living (BKD) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Brookdale (BKD) delivered earnings and revenue surprises of 69.77% and 1.09%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Will Brookdale Senior Living (BKD) Report Negative Q4 Earnings? What You Should Know
by Zacks Equity Research
Brookdale (BKD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ensign Group (ENSG) Matches Q4 Earnings Estimates
by Zacks Equity Research
Ensign Group (ENSG) delivered earnings and revenue surprises of 0% and 1.22%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Down -8.3% in 4 Weeks, Here's Why Brookdale (BKD) Looks Ripe for a Turnaround
by Zacks Equity Research
The heavy selling pressure might have exhausted for Brookdale (BKD) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Brookdale Senior Living (BKD) Q4 Weighted Average Occupancy Up
by Zacks Equity Research
Brookdale Senior Living (BKD) witnesses 14 straight months of year-over-year increases in weighted average occupancy level.
Brookdale Senior Living (BKD) Reports Q3 Loss
by Zacks Equity Research
Brookdale (BKD) delivered earnings and revenue surprises of -15.38% and 0%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Brookdale Senior Living (BKD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Brookdale (BKD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ensign Group (ENSG) Q3 Earnings Lag Estimates
by Zacks Equity Research
Ensign Group (ENSG) delivered earnings and revenue surprises of -0.95% and 2.71%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Acadia (ACHC) JV Breaks Ground for New Behavioral Health Unit
by Zacks Equity Research
Acadia Healthcare (ACHC) and Henry Ford Health expect the new hospital to start with 184 inpatient beds and later expand to 192 beds.
Brookdale (BKD) Shows Fast-paced Momentum But Is Still a Bargain Stock
by Zacks Equity Research
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Brookdale (BKD) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Has Brookdale Senior Living (BKD) Outpaced Other Medical Stocks This Year?
by Zacks Equity Research
Here is how Brookdale Senior Living (BKD) and Hanger (HNGR) have performed compared to their sector so far this year.
All You Need to Know About Brookdale (BKD) Rating Upgrade to Buy
by Zacks Equity Research
Brookdale (BKD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Brookdale Senior Living (BKD) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Brookdale (BKD) delivered earnings and revenue surprises of -9.76% and 0.75%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Ensign Group (ENSG) Meets Q2 Earnings Estimates
by Zacks Equity Research
Ensign Group (ENSG) delivered earnings and revenue surprises of 0% and 0.60%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Brookdale Senior Living (BKD) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
by Zacks Equity Research
Brookdale (BKD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Brookdale Senior Living (BKD) Reports Q1 Loss, Tops Revenue Estimates
by Zacks Equity Research
Brookdale (BKD) delivered earnings and revenue surprises of -45.95% and 1.06%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Ensign Group (ENSG) Surpasses Q1 Earnings and Revenue Estimates
by Zacks Equity Research
Ensign Group (ENSG) delivered earnings and revenue surprises of 3.13% and 1.78%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Brookdale Senior Living (BKD) Expected to Beat Earnings Estimates: What to Know Ahead of Q1 Release
by Zacks Equity Research
Brookdale (BKD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.